Lucid Diagnostics Inc. (LUCD) NASDAQ

1.08

+0.01(+0.93%)

Updated at November 07 04:00PM

Currency In USD

Valuation

Market Cap41.36M
Enterprise Value40.25M
P/E Ratio-1.93
PEG Ratio-0.15
Price/Sales Ratio25.21
Price/Book Ratio13.6
Enterprise/Revenue24.39
Enterprise/EBITDA-1.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-12.67
Operating Margin-11

Management Effectiveness

Return On Assets-1.43
Return On Equity-15.55

Income Statement

Revenue4.35M
Revenue/Share0.04
Gross Profit-3.92M
EBITDA-44.34M
Net Income-45.53M
Diluted EPS-1.05

Balance Sheet

Total Cash31.12M
Total Cash/Share0.31
Total Debt27.55M
Total Debt/Equity3.5
Current Ratio1.15
Book Value Per Share0.08

Price History

52-Week Change3.85
52-Week High1.8
52-Week Low0.75
Moving Average 50 Days1.15
Moving Average 200 Days1.21

Statistics

Average Volume1.18M
Shares Outstanding101.76M
% Held by Institutions18.33

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A